🇧🇪
Western EuropeBelgium
Belgium is a biotech powerhouse relative to its size, with Ghent as a globally recognized hub for cell and gene therapy. UCB, Galapagos, and argenx have put Belgium on the biotech map.
Biotech Market Cap
$73.9B
Public Companies
14
Total Companies
134
30D Performance
-8.77%
BIOTECH MARKET CAP INDEX
$73.9B+6531.7%ALL
BIOTECH HUBS
GhentLeuvenBrusselsMechelen
COMPANIES
| # | Company | Valuation |
|---|---|---|
| 1 |  | $113.3B |
| 2 |  | $52.5B |
| 3 |  | $32.7B |
| 4 |  | $16.9B |
| 5 |  | $10.5B |
| 6 | | $4.0B |
| 7 |  | $2.1B |
| 8 |  | $1.9B |
| 9 |  | $1.2B |
| 10 |  | $688.3M |
| 11 |  | $554.0M |
| 12 |  | $169.6M |
| 13 |  | $137.8M |
| 14 |  | $102.0M |
| 15 |  | $56.3M |
| 16 |  | $17.3M |
| 17 |  | $418.0K |
| 18 |  | — |
| 19 |  | — |
| 20 |  | — |
1–20 of 134
Page 1 of 7